LIB003

· LIB Therapeutics LLC

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for LIB003, covering 2018-07-27 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients [Phase 3]